Delivery Order SPE2DB22D3004-SPE2DB24FNL58
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 1, 2024. The contract is a Delivery Order valued at $1,437.58 for the supply of a 4% Lidocaine HCL solution, with a period of performance through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of 4,565,294,512 units of 4% lidocaine hydrochloride solution in 4 mL vials, with a ceiling value of $1,516.98 and a completion date of July 31, 2024. This delivery order is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of a lidocaine hydrochloride 4% solution. The $2,022.64 delivery order is a firm-fixed price contract with a completion date of May 31, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp. is a $1,079.27 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The contract is for the provision of 4% Lidocaine HCL solution, a common local anesthetic medication. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. The IDC...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.55 firm-fixed-price contract is for the supply of 4% Lidocaine HCL Solution, a topical anesthetic, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,191.54 firm fixed price delivery order is for the supply of 4% lidocaine hydrochloride solution (4 ml) to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, identified as SPE2DB22D3004|SPE2DB25FQK17, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,204.74 firm fixed-price delivery order is for the supply of 4,568,012,946 units of Lidocaine HCL 4% Solution 4ML, a pharmaceutical product, with a performance period through April 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
- This is a $5,553.01 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565425592 - Lidocaine HCL 4% Solution 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024 and is a firm fixed price, no set-aside contract. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.64 firm fixed-price delivery order is for the supply of 50 ml vials of 1% Lidocaine HCL, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.98 firm fixed price delivery order contract is for the supply of Lidocaine HCL 2% Luer-Jet 5ML, a medical product used for various healthcare applications. The contract is non-set-aside and has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FNL58Delivery Order
This federal contract award with ID SPE2DB22D3004|SPE2DB24FNL58 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,168.66 firm fixed-price delivery order is for the supply of 4% Lidocaine HCl solution. The contract has an ultimate completion date of November 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that broader IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/14/23 |